Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Spondylitis, Ankylosing 1Psoriasis 1Lymphoma, Follicular 1

Interventions

Fluticasone-Salmeterol Drug Combination 2Fluticasone 2Diclofenac 2ziconotide 1secukinumab 1ropinirole 1aliskiren 1acetaminophen, codeine drug combination 1Venlafaxine Hydrochloride 1Thiotepa 1Tacrolimus 1Sublocade 1Ribavirin 1Radiotherapy 1Quinine 1Oxycodone 1Naloxone 1Ketamine 1Furosemide 1Filgrastim 1Fentanyl 1Escitalopram 1Donepezil 1Cyclophosphamide 1Buprenorphine, Naloxone Drug Combination 1Bimatoprost 1Artesunate 1Antilymphocyte Serum 1Amoxicillin-Potassium Clavulanate Combination 1Amlodipine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lymphoma, Follicular × secukinumab × Clear all
NCT04571567 2022-04-11

A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis

Icahn School of Medicine at Mount Sinai

Phase 4 Completed
20 enrolled
Lymphoid

Lymphoma, Follicular, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡